ICG-NIR Guided Lymph Node Dissection in Gastric Cancer
Not Applicable
- Conditions
- Stomach Neoplasm
- Interventions
- Procedure: ICG-NIR guided surgery
- Registration Number
- NCT04056260
- Lead Sponsor
- Ho Seok Seo
- Brief Summary
As the survival rate of patients with gastric cancer has increased, there has been a growing interest in interventions that improve postoperative quality of life. Therefore minimally invasive surgery or endoscopic resection has been performed much more frequently. However, adequate lymph node dissection is important as well. The aim of the study is to identify the feasibility of indocyanine green - near infra-red (ICG-NIR) guided sentinel lymph node dissection for the treatment of gastric cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 219
Inclusion Criteria
- dignosed gastric adenocarcinoma
- tumor: size 4cm or smaller
- depth of invasion: mucosa, submucosa, proper muscle
- candidates of laparoscopic radical gastrectomy
- informed consent
Exclusion Criteria
- metachronous malignancy
- number of tumors: 2 or more
- remnant gastric cancer
- indication for endoscopic resection
- history of chemotherapy or radiation therapy
- pregnancy
- allergy to ICG
- metastatic gastric cancer
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description ICG injection ICG-NIR guided surgery ICG 0.5mg/ml x 0.5ml x 4 sites
- Primary Outcome Measures
Name Time Method sensitivity and specificity 1 month sensitivity and specificity of ICG-NIR guided lymph node dissection
- Secondary Outcome Measures
Name Time Method